salmeterol xinafoate has been researched along with Disease Models, Animal in 2 studies
salmeterol : A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation.
2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol : A phenol having a hydroxymethyl group at C-2 and a 1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl group at C-4; derivative of phenylethanolamine.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsen, JR | 2 |
| Aggen, JB | 1 |
| Church, TJ | 1 |
| Klein, U | 2 |
| Pfeiffer, JW | 2 |
| Pulido-Rios, TM | 1 |
| Thomas, GR | 2 |
| Yu, C | 2 |
| Moran, EJ | 2 |
| McKinnell, RM | 1 |
| Linsell, MS | 1 |
| Nodwell, MB | 1 |
2 other studies available for salmeterol xinafoate and Disease Models, Animal
| Article | Year |
|---|---|
Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines.
Topics: Adrenergic beta-2 Receptor Agonists; Amines; Animals; Disease Models, Animal; Dose-Response Relation | 2014 |
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Cell Line; Diphenylamine; Disease Models, Anim | 2014 |